From Harvard’s Springer Gets $51.5M From Pharmas, Others, For Latest Startup:

Tim Springer
Tim Springer—

Tim Springer is an immunologist at Harvard University and the scientific founder of Morphic Therapeutics.

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

© 2007-2021, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.